Outset Medical
NASDAQ: OMUnicorn · $2.3BSan Jose, US · Delaware corporation · 573 employees on LinkedIn · 5 known investors
Find your way into Outset Medical
982 people in our graph share verified history with the Outset Medical team — schools, employers, funds. One of them is your warm intro.
Michael Klaykounlockedknows John Brottem · together at Brocade (overlapped)
×2knows the team · via Waseda University
knows the team · via University of Haifa
×3knows the team · via University of Oklahoma
×2knows the team · via Occidental College
knows the team · via Union College
Outset Medical develops dialysis technology aimed at driving broader adoption and lowering the cost of care for patients and healthcare providers. The company manufactures in North America and operates across the United States.
Founders & leadership
NA
Nabeel AhmedinChief Financial Officer2021–2025
MN
Marc NashinExecutive Vice President of Operations R&D and ServiceMarc Nash is an executive officer at Outset Medical with over 20 years of experience in medical device operations, manufacturing strategy, and quality management. He has held leadership roles focused on operational scaling, process development, and regulatory compliance.
JB
John BrotteminGeneral CounselJohn Brottem is General Counsel of Outset Medical, which develops dialysis technology. He has experience in mergers and acquisitions, securities offerings, SEC reporting and compliance, and corporate governance.
LT
Leslie TrigginChair and Chief Executive Officer
JM
Jeff MackinCFO2015–2019Finance executive with over 20 years of experience in enterprise FP&A, M&A, and capital markets across medical device, high-tech, and operations sectors. Mack previously served as director of finance and acting CFO at The North Face, led financial operations at a ski resort, and held audit roles at Deloitte & Touche; he holds a CPA license in California.
RG
Renee GaetainChief Financial OfficerRenee Gaeta is Chief Financial Officer of Outset Medical, which develops dialysis technology for North American healthcare providers. She has prior experience as a public company CFO and board member with expertise in IPO execution, financial planning, investor relations, and M&A.
MA
Michael AragoninChief Medical OfficerMichael Aragon is a board-certified internist and nephrologist with 15 years of clinical experience, including prior roles as medical director at DaVita and U.S. Renal Care, and has conducted research on home dialysis expansion for patients with renal disease. He serves as Chief Medical Officer of Outset Medical.
BM
Brittni McGillinChief Nursing OfficerChief Nursing Officer at Outset Medical, McGill previously led clinical healthcare operations and established nursing residency and development programs in partnership with academic institutions including the University of Oklahoma Health Sciences Center.
Board
Investors · 5
Reported raises · per SEC filings
Form D private placements$390.9M disclosed across 6 rounds · 2015–2025
▶$3.9MraisedJan 2025 · 13 investors · Other Health CareRule 506(b)
▶$3.9MraisedJan 2025 · 13 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Keith GrossmanDirector
- Patrick T. HackettDirector
- Andrea SaiaDirector
- Nabeel AhmedExecutive Officer
- Dale JonesDirector
- Brent LangDirector
- Karen DrexlerDirector
- Marc NashExecutive Officer
- John BrottemExecutive Officer
- Leslie TriggDirector
- Offering amount
- $3.9M
- Amount sold
- $3.9M
- First sale
- Jan 2025
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$115MraisedFeb 2020 · 20 investors · Other Health CareRule 506(b)
▶$115MraisedFeb 2020 · 20 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Rebecca ChambersExecutive Officer
- Patrick HackettDirector
- Rohit VishnoiDirector
- D. Keith GrossmanDirector
- Leslie TriggExecutive Officer, Director
- Thomas J. CarellaDirector
- Camilla Macapili LanguilleDirector
- Scott BartosDirector
- Offering amount
- $128.5M
- Amount sold
- $115M
- First sale
- Jan 2020
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$131.7MraisedAug 2018 · 27 investors · Other Health CareRule 506(b)
▶$131.7MraisedAug 2018 · 27 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Annette RodriguezDirector
- Jeff MackExecutive Officer
- D. Keith GrossmanDirector
- Scott BartosDirector
- Leslie TriggExecutive Officer, Director
- Rohit VishnoiDirector
- In Seon HwangDirector
- Camilla Macapili LanguilleDirector
- Offering amount
- $143.1M
- Amount sold
- $131.7M
- Minimum investment
- $1
- First sale
- Aug 2018
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$4.3MraisedJun 2017 · 1 investors · Other Health CareRule 506(b)
▶$4.3MraisedJun 2017 · 1 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Jeff MackExecutive Officer
- Tony ChouDirector
- In Seon HwangDirector
- Annette RodriguezDirector
- Rohit VishnoiDirector
- D. Keith GrossmanDirector
- Leslie TriggExecutive Officer, Director
- Scott BartosDirector
- Offering amount
- $4.3M
- Amount sold
- $4.3M
- Minimum investment
- $1
- First sale
- Jun 2017
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$76.5MraisedMay 2017 · 27 investors · Other Health CareRule 506(b)
▶$76.5MraisedMay 2017 · 27 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Annette RodriguezDirector
- In Seon HwangDirector
- D. Keith GrossmanDirector
- Scott BartosDirector
- Jeff MackExecutive Officer
- Leslie TriggExecutive Officer, Director
- Tony ChouDirector
- Rohit VishnoiDirector
- Offering amount
- $76.5M
- Amount sold
- $76.5M
- Minimum investment
- $1
- First sale
- Apr 2017
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$59.6MraisedMay 2015 · 11 investors · Other Health CareRule 506(b)
▶$59.6MraisedMay 2015 · 11 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Bess WeathermanDirector
- Jeff MackExecutive Officer
- Scott BartosDirector
- D. Keith GrossmanDirector
- Tony ChouDirector
- Rohit VishnoiDirector
- Noah KnaufDirector
- Leslie TriggExecutive Officer, Director
- Offering amount
- $65.6M
- Amount sold
- $59.6M
- Minimum investment
- $1
- First sale
- May 2015
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Valuation · disclosed
Disclosed events$2.3Bvaluation at IPOApr 2021 · $53.50/share · 424B4
filing ↗Source: SEC prospectus filings, and round valuations the company or its investors disclosed — follow each entry's link for the claim.
Competitors · 2
by search overlapKidney271 shared keywordsThe National Kidney Foundation works to eliminate preventable kidney disease, accelerate innovation in patient care, and address structural inequities in kidney treatment and transplantation services. The organization serves patients with kidney disease and at-risk communities.
Renaltracker129 shared keywordsRenalTracker provides dietitian-designed nutrition management tools and programs for patients with chronic kidney disease to help them avoid dialysis and improve health outcomes. The platform serves kidney patients aged 60+ with science-backed food lists and personalized dietary guidance.
Companies competing with Outset Medical for the same Google search keywords, organic and paid, via search-intersection analysis.
In the news
Frequently asked questions
- What does Outset Medical do?
- Outset Medical develops dialysis technology aimed at driving broader adoption and lowering the cost of care for patients and healthcare providers. The company manufactures in North America and operates across the United States.
- Who are Outset Medical's investors?
- Outset Medical's investors include The Vertical Group, Durable Capital Partners, Fidelity Investments, T. Rowe Price, Warburg Pincus.
- How much funding has Outset Medical raised?
- Outset Medical has disclosed $390.9M raised across 6 rounds.
- Where is Outset Medical headquartered?
- Outset Medical is headquartered in San Jose, US.